Global Coronary Artery Bypass Graft Market By Product Type (Saphenous Vein Grafts, Internal Thoracic Artery Grafts, and Other Grafts), By Surgery Procedure (Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, and Others), By Technology (On-Pump CABG and Off-Pump CABG), By Technique (Conventional Vessel Harvesting and Endoscopic Vessel Harvesting), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032
- Published date: Jul 2022
- Report ID: 47718
- Number of Pages: 387
- Format:
- keyboard_arrow_up
Coronary Artery Bypass Graft Market Overview:
The global market for coronary artery bypass grafts was estimated to be worth USD 87 million in 2021. This market is estimated to grow at a rate of 6.10% over the forecast period.
Increased prevalence of disorders such as hypertension, Coronary Heart Disease, Coronary Artery Disease, Myocardial Infarction, Myocardial Infarction, and peripheral artery disease. In addition, technologically advanced devices are also likely to boost this market expansion.
CVDs, which can be caused due to poor lifestyle choices, stress, or eating fast food are some of the primary causes of death in the world. According to WHO, cardiovascular diseases are the most common cause of death.
Globally, 31.0 % of fatalities were due to cardiovascular disease (CVD). They were responsible for approximately 17.5 Mn deaths in 2012. Around 6.4 Mn to stroke and 7.4 Mn of these 17.5 Mn deaths could be attributed to heart disease. It is expected that by 2032, the death toll will be around 23.6 Mn.
Global Coronary Artery Bypass Graft Market Analysis
Graft Type Analysis
The market analysis focuses on the saphenous vein and internal thoracic artery graft segments. The saphenous vein graft segment registered the highest market share in 2021. It is projected to grow at a profitable rate in the future. The demand for Saphenous Vein Grafts (SVG), which are more flexible, easier to handle, and require less transfusion, has increased in the market for coronary bypass grafts.
The radial and gastroepiploic arteries are then separated from the rest of the graft. The Right Gastroepiploic Artery is a conduit for coronary bypass surgery that is an alternative to the left coronary artery. It’s utilized to harvest grafts from patients who don’t have enough saphenous veins.
Surgical Procedure Analysis
Due to the rising prevalence of CVDs like CAD, CHD, or strokes worldwide, the triple CABG surgery segment will dominate this industry. The procedure of a double bypass is very widespread globally. This will be the highest and most profitable market, with a high CAGR expected over the projected period.
Technology Analysis
The on-pump market was the largest segment in 2021. The market has developed significantly as a result of the increased use of oxygenators, machines for heart-lung, stabilizers, positioners, and cardiac and cardiothoracic surgeons’ predilection for on-pump CABG surgeries.
The off-pump segment will increase its market share over the projection period. With the development of innovative techniques like (TECAB) and Totally Endoscopic Coronary Artery Bypass, this vertical is likely to grow.
Technique Analysis
The conventional vessel harvesting segment will dominate the market owing to its use in graft surgeries of the coronary bypass which has increased. The introduction of endoscopic vessel harvesting techniques is projected to lower this segment’s market share. They are less prone than standard longitudinal incisions to cause scarring, infection, or morbidity, which can lead to better outcomes.
Over the projection period, EVH’s market share is likely to grow. This portion eliminates the requirement for extensive incisions, which are necessary with traditional open harvesting. It reduces postoperative discomfort, lowers the incidence of infection of wounds, and improves patient satisfaction.
Key Market Segments
By Graft Type
- Internal Thoracic Artery Grafts
- Saphenous Vein Grafts
- Other Grafts
- Radial Artery
- Gastroepiploic Artery
By Surgical Procedure
- Quadruple CABG Surgery
- Triple CABG Surgery
- Double CABG Surgery
- Single CABG Surgery
By Technology
- Off-Pump CABG
- On-Pump CABG
By Technique
- Endoscopic Vessel Harvesting
- Conventional Vessel Harvesting
Market Dynamics
Globally, the geriatric population is expected to drive the increase in coronary artery bypass surgery. This will bolster the growth of the vertical over the forecast period. The American Heart Association (AHA), estimates that the global geriatric population will account for around 20.0% of the world’s total population by 2032.
According to the AHA statistics, 5,19,000 CAB-G procedures were performed in the United States in 2012. Of these, 371,000 were men and 148,000 on females. According to estimates, more than 800,000. CABG surgeries are performed each year worldwide.
Over the forecast period, the demand for CABG surgery is expected to rise due to the introduction of new technologies such as Minimally Invasive Direct Coronary Artery Bypass or keyhole, Anasist Devices(AAD), and Endoscopic Vessel Harvesting. MIDCAB, a less invasive CABG procedure, allows for easier access to the heart via a smaller incision.
MIDCAB uses off-pump technology and is performed without the use of a heart-lung machine. MIDCAB has many benefits, including faster recovery, less bleeding & blood trauma and lower infection rates, as well as a low cost of surgery.
Regional Analysis
North America accounted for 56.9% of the coronary artery bypass graft market share in 2021. This is due to increasing CVD prevalence, the presence, and changing lifestyles of people in Canada and the US.
APAC had a significant market share in 2021. This was because of the increasing number of coronary artery bypass graft procedures in Japan and India. Moreover, due to growing patient awareness and growing population about these diseases this market is growing in this region. Europe is likely to see a high CAGR relative to the past owing to the high figure of CABG operations performed in Europe.
Key Regions and Countries covered іn thе rероrt:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Russia
- Spain
- Rest of Europe
- APAC
- China
- Japan
- South Korea
- India
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- MEA
- GCC
- South Africa
- Israel
- Rest of MEA
Market Share & Key Players Analysis:
The key players in this market include Medtronic plc, Terumo Corporation, Guidant Corporation, Maquet, Vitalitec International GmbH, Novadaq Inc., KARL STORZ SE & Co. KG, and Edwards Lifesciences. These companies are focused on growth approaches or strategies like acquisition and merger, product launch as well as regional expansion.
Маrkеt Кеу Рlауеrѕ:
- Medtronic plc
- Terumo Corporation
- Guidant Corporation
- Maquet Vitalitec
- International GmbH
- Novadaq Technologies Inc.
- KARL STORZ SE & Co. KG
- Edwards Lifesciences
- Other Key Players
For the Coronary Artery Bypass Graft Market research study, the following years have been considered to estimate the market size:
Attribute Report Details Historical Years
2016-2020
Base Year
2021
Estimated Year
2022
Short Term Projection Year
2028
Projected Year
2023
Long Term Projection Year
2032
Report Coverage
Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.
Regional Scope
North America, Europe, Asia-Pacific, South America, Middle East & Africa
Country Scope
United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa
Frequently Asked Questions (FAQ)
Q: What is the Coronary Artery Bypass Graft market size in 2021?A: The Coronary Artery Bypass Graft market size is US$ 87.0 million in 2021.
Q: What is the CAGR for the Coronary Artery Bypass Graft market?A: The Coronary Artery Bypass Graft market is expected to grow at a CAGR of 6.1 % during 2023-2032.
Q: What are the segments covered in the Coronary Artery Bypass Graft market report?A: Market.US has segmented the Global Coronary Artery Bypass Graft Market Value (US$ Mn) Analysis by Region, 2022 market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Product Type the market is segmented into Saphenous Vein Grafts, Internal Thoracic Artery Grafts, and Other Grafts. In terms of Surgery Procedure, the market is divided into Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, and Quadruple CABG Surgery. In terms of Technology the market is bifurcated into On-Pump CABG and Off-Pump CABG. And in terms of Technique, the market is classified into Conventional Vessel Harvesting and Endoscopic Vessel Harvesting.
Q: Who are the key players in the Coronary Artery Bypass Graft market?A: Medtronic plc, Terumo Corporation, Guidant Corporation, Maquet, Vitalitec International GmbH, Novadaq Technologies Inc., KARL STORZ SE & Co. KG, Edwards Lifesciences, Other Key Players are the key vendors in the Coronary Artery Bypass Graft market.
Q: Which region is more attractive for vendors in the Coronary Artery Bypass Graft market?A: North America is accounted for the highest revenue share of 56.9% among the other regions. Therefore, the Coronary Artery Bypass Graft market in APAC is expected to garner significant business opportunities for the vendors during the forecast period.
Q: What are the key markets for Coronary Artery Bypass Graft?A: Key markets for Coronary Artery Bypass Graft are the US, Canada, India, Japan, etc.
Q: Which segment has the largest share in the Coronary Artery Bypass Graft market?A: In the Coronary Artery Bypass Graft market, vendors should focus on grabbing business opportunities from the saphenous vein graft segment as it accounted for the largest market share in the base year.
Coronary Artery Bypass Graft MarketPublished date: Jul 2022add_shopping_cartBuy Now get_appDownload Sample - Medtronic plc
- Terumo Corporation Company Profile
- Guidant Corporation
- Maquet Vitalitec
- International GmbH
- Novadaq Technologies Inc.
- KARL STORZ SE & Co. KG
- Edwards Lifesciences
- Other Key Players
- settingsSettings
Our Clients
Single User
$5,999
$2,999
USD / per unit
save 50% |
Multi User
$7,999
$3,499
USD / per unit
save 55% |
Corporate User
$12,999
$4,499
USD / per unit
save 65% | |
---|---|---|---|
e-Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 2,999) | Buy Now ($ 3,499) | Buy Now ($ 4,499) |